We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Novel Biomarkers in Chronic Airway Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00849836
Recruitment Status : Unknown
Verified February 2009 by Chonbuk National University.
Recruitment status was:  Recruiting
First Posted : February 24, 2009
Last Update Posted : February 24, 2009
Sponsor:
Information provided by:

February 23, 2009
February 24, 2009
February 24, 2009
February 2009
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Novel Biomarkers in Chronic Airway Diseases
The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders

The purpose of this study is:

  • To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
  • To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Patients with acute exacerbation of asthma or COPD, patients with stable status of those disease, and the healthy control subjects
  • Asthma
  • COPD
Not Provided
  • Acute exacerbation
  • Stable disease
  • Healthy control
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
30
January 2010
Not Provided

Inclusion Criteria:

  • > 18 years olds
  • Both sexes
  • Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
  • Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
  • For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT00849836
RCPD
Not Provided
Not Provided
Not Provided
Yong Chul Lee, Chonbuk National University Medical School
Chonbuk National University
Not Provided
Not Provided
Chonbuk National University
February 2009